Videos

Videos

2020

AMP – Invivoscribe Virtual Workshop

Invivoscribe’s Virtual Workshop | AMP 2020
Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing. Artificial Intelligence (AI) and other Data Science Applications in Molecular Pathology.

AMP – Invivoscribe Virtual Workshop
Featured Presenters Yury Monczak, Ph.D / Ryan J. Schmidt, MD, PhD

Clinical Utility of NGS in Lymphoid Malignancies including Minimal Residual Disease (MRD) testing

AMP – Invivoscribe Virtual Workshop
Featured Presenter Dr. Bradley Patay

Artificial Intelligence (AI) and other Data Science Applications in Molecular Pathology

2020

JHS – Invivoscribe Virtual Workshop

Invivoscribe’s Virtual Workshop | JHS 2020
Leukemia, Precision Medicine and New Molecular Targeted Therapies

JHS – Invivoscribe Virtual Workshop
Featured Speakers Yosuke Minami, M.D. Ph.D. / Ken-ichi Matsuoka, M.D. Ph.D.

Leukemia, Precision Medicine and New Molecular Targeted Therapies

2020

VIRTUAL EHA – Virtual Video Series

Invivoscribe’s Virtual EHA 2020 | VIRTUAL | June 11 – 14, 2020 | On Demand Until October 15th
NGS-Based Clinical Assessment of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection

Invivoscribe Virtual 25th EHA Annual Congress
Featured Presenter Dr. Maria Arcila

Incorporating NGS Methods for Routine Clonality Assessment and Disease Monitoring of Lymphoid Malignancies presented by Dr. Maria Arcila – Memorial Sloan Kettering Cancer Center, NY, United States

Invivoscribe Virtual 25th EHA Annual Congress
Featured Presenter Prof. Sara Galimberti

Clonality analysis with NGS is the new frontier in MRD detection presented by Prof. Sara Galimberti – University of Pisa, Department of Clinical and Experimental Medicine, Italy

Invivoscribe Virtual 25th EHA Annual Congress
Featured Presenter Prof. Dr. Markus Tiemann

Next Generation Analysis in CLL and Other Malignancies presented by Prof. Dr. Markus Tiemann – Institute for Hematopathology Hamburg, Germany

2019

EHA – (3) Part Video Series

Invivoscribe’s Symposium at EHA 2019 | Amsterdam, The Netherlands | June 13, 2019
Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.

Invivoscribe – EHA 2019 Video Series Part (1) of 3
Featured Speaker Marleen Bakkus

Invivoscribe – EHA 2019 (3) Part Video Series
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.
Clonality Assessment and MRD Analysis in Acute Lymphoblastic Leukemia and Multiple Myeloma Using the LymphoTrack Dx NGS Assays.
Featured Speaker: Marleen Bakkus – Laboratory for Molecular Hematology, UZ Brussel, University Hospital Brussels, Brussel, Belgium

Invivoscribe – EHA 2019 Video Series Part (2) of 3
Featured Speaker Marc Seifert

Invivoscribe – EHA 2019 (3) Part Video Series
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.
Analysis of Human BCR Rearrangement Repertoires in Health and Disease.
Featured Speaker: Marc Seifert – Institute of Cell Biology (Tumor Research), AG Immunology and Lymphomagenesis, Essen University Hospital, Essen, Germany

Invivoscribe – EHA 2019 Video Series Part (3) of 3
Featured Speaker Fiona Quinn

Invivoscribe – EHA 2019 (3) Part Video Series
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Molecular Clinical Assessment and Monitoring of Hematologic Malignancies: B- and T-Cell Clonality, SHM and MRD Detection.
B- and T-Cell Clonality Analysis and CLL IGHV Mutational Status – an Overview.
Featured Speaker: Fiona Quinn – Cancer Molecular Diagnostics Dept., St. James’s Hospital, Dublin, Ireland

ASCO

Invivoscribe – ASCO 2019 LeukoStrat CDx FLT3 Mutation Assay Presentation | Chicago, IL | June 01, 2019
Featured Speaker Dr. Bradley Patay, Invivoscribe’s Chief Medical Officer Presents Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay at Chicago Firehouse Grill.

Invivoscribe – ASCO – LeukoStrat CDx FLT3 Mutation Assay
Featured Speaker Dr. Bradley Patay

Invivoscribe – ASCO – LeukoStrat CDx FLT3 Mutation Assay
Invivoscribe’s Symposium at EHA 2019 in Amsterdam, The Netherlands – June 13, 2019
Topic: Invivoscribe’s LeukoStrat CDx FLT3 Mutation Assay
Featured Speaker: Dr. Bradley Patay, Invivoscribe, Chief Medical Officer

AMP GLOBAL – (4) Part Video Series

Invivoscribe – AMP Global 2019 | Hong Kong | May 16, 2019
NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.

Invivoscribe – AMP Global 2019
Video Series Part (1) of 4

Featured Speaker Bettina Budeus

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
Analysis of Human BCR Rearrangement Repertoires in Health and Disease.
Featured Speaker: Bettina Budeus – Group Molecular Genetics, Essen University Hospital, Essen, Germany

Invivoscribe – AMP Global 2019
Video Series Part (2) of 4

Featured Speaker Roshanak Bob

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
A Practical Interpretation of Clonality Results, IdentiClone and LymphoTrack Assays in Daily Diagnosis.
Featured Speaker: Roshanak Bob – Berlin Reference Center for Lymphoma and Hematopathology, Berlin, Germany

Invivoscribe – AMP Global 2019
Video Series Part (3) of 4

Featured Speaker Oliver Giles Best

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
Analysis of IGHV Mutational Status, T-Cell Clonality and MRD by NGS.
Featured Speaker: Oliver Giles Best – CLL Research Laboratory, Northern Blood Research Centre, Kolling Institute of Medical Research, University of Sydney, Royal North Shore Hospital, St Leonards, Sydney, Australia

Invivoscribe – AMP Global 2019
Video Series Part (4) of 4

Featured Speaker Piers Blombery

Invivoscribe – AMP Global 2019 (4) Part Video Series
Invivoscribe’s Symposium at AMP Global 2019 – Hong Kong, May 16th
Topic: NGS Solutions for the Assessment of Clonality and Somatic Hypermutation (SHM) in Hematologic Malignancies.
Case Studies of IGHV Analysis and NGS Mutation Detection in Lymphoid Malignancy.
Featured Speaker: Piers Blombery – Peter MacCallum Cancer Centre, Melbourne, Australia